{"url_path":"/sec/ndra/8-k/2026-06-25/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-071804-index.html","accession_number":"0001213900-26-071804","cik":"0001681682","ticker":"NDRA","issuer_name":"ENDRA Life Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-071804-index.html","primary_entity_key":"0001681682","primary_entity_name":"ENDRA Life Sciences Inc."},"word_count":84,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Number**\n \n**Description**\n\n99.1\n \n[Press Release dated June 25, 2026, furnished herewith](ea029589901ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n1\n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**ENDRA Life Sciences Inc.**\n\n \n \n\nJune 25, 2026\n \n\n \nBy:\n/s/ Alexander Tokman\n\n \nName:\nAlexander Tokman\n\n \nTitle:\nChief Executive Officer and Chairman\n\n \n\n2"}